Health ❯ Chronic Diseases

Obesity

Diabetes Type 2 Diabetes Dietary Impact Health Risks Metabolic Disorders Treatment Options Weight Management Metabolic Syndrome Heart Disease Hypertension

GLP‑1 Market Set to Balloon as Oral Pill Wins US Approval

US clearance of an oral GLP‑1 expands access while regulators and health systems confront supply strains, safety reports and care gaps.

Plant-Forward and Low‑Insulinemic Diets Linked to Less Weight Gain During Menopause

Too Little or Too Much Sleep Speeds Organ Aging, Study Finds

Massive Study Ties 6–8 Hours of Sleep to Slower Biological Ageing

Cardiology Groups Urge Doctors To Screen For Ultra-Processed Food Intake

Cardiology Experts Link Ultra-Processed Foods to Higher Heart Risks

Boehringer’s Dual-Agonist Survodutide Cuts Body Weight by Up to 16.6% in Phase III Trial

Ultra-Processed Foods Linked to Higher Thigh Muscle Fat in MRI Study

Obesity Before 30 Tied to Much Higher Risk of Early Death, Swedish Study Finds

India’s ‘Mounjaro Bride’ Trend Fuels Pre‑Wedding Use of GLP‑1 Weight‑Loss Shots

Study Finds Distinct Cardiometabolic Risks for Men and Women With Obesity

JW Pharmaceutical Licenses Korean Rights to Gan & Lee’s GLP-1 Drug in Deal Worth Up to $81 Million

Monthly Binge Drinking Linked to Triple Risk of Advanced Liver Scarring in MASLD

Ultra-Processed Foods Tied to Sharply Higher Heart Risk in New 12-Year U.S. Study

Roche Expands NVIDIA Partnership, Building Pharma’s Largest Hybrid‑Cloud AI Factory

Mexico Launches 500,000-Person Obesity Study in New National Strategy as Regional Alarms Grow

Eli Lilly Unveils Employer Connect, Offering Zepbound to Employers at a Uniform $449 Net Price

Mexico Launches National Strategy to Slow Obesity on World Obesity Day

World Obesity Day: Diagnoses Climb as Policy Momentum Builds and Services Scale Up

Novo Nordisk Licenses Vivtex Platform in $2.1 Billion Push for Oral Obesity and Diabetes Drugs